The COVID-19 pandemic fundamentally transformed public health supply chain management in the United States, exposing critical vulnerabilities while simultaneously demonstrating the importance of robust procurement and distribution systems. This study evaluates how pandemic response experiences have reshaped preparedness strategies, drawing particular insights from established HIV/TB supply chain management programs. Through comprehensive analysis of supply chain disruptions, government responses, and lessons learned from mature HIV/TB procurement systems, this research reveals that successful public health supply chains require strategic diversification, enhanced visibility, and institutionalized resilience mechanisms. The COVID-19 pandemic disrupted supply chains unevenly, with life sciences thriving while exposing vulnerabilities such as staff shortages and halting the flow of materials. Key findings demonstrate that while COVID-19 catalyzed unprecedented innovation in supply chain management, the sustainability of these improvements depends on sustained investment, coordination across federal and state levels, and integration of lessons from established programs like PEPFAR's successful HIV/AIDS supply chain infrastructure.
Mercy Oluwaseun Itopa (Sat,) studied this question.